...
首页> 外文期刊>European journal of pharmaceutics and biopharmaceutics: official journal of Arbeitsgemeinschaft fuer Pharmazeutische Verfahrenstechnik e.V >Poly(ethylene oxide)-poly(propylene oxide) block copolymer micelles as drug delivery agents: improved hydrosolubility, stability and bioavailability of drugs.
【24h】

Poly(ethylene oxide)-poly(propylene oxide) block copolymer micelles as drug delivery agents: improved hydrosolubility, stability and bioavailability of drugs.

机译:聚(环氧乙烷)-聚(环氧丙烷)嵌段共聚物胶束作为药物输送剂:提高了药物的水溶性,稳定性和生物利用度。

获取原文
获取原文并翻译 | 示例
           

摘要

The low solubility in biological fluids displayed by about 50% of the drugs still remains the main limitation in oral, parenteral, and transdermal administration. Among the existing strategies to overcome these drawbacks, inclusion of hydrophobic drugs into polymeric micelles is one of the most attractive alternatives. Amphiphilic poly(ethylene oxide)-poly(propylene oxide) block copolymers are thermoresponsive materials that display unique aggregation properties in aqueous medium. Due to their ability to form stable micellar systems in water, these materials are broadly studied as hydrosolubilizers for poorly water-soluble drugs. The present review provides a concise description of the most important applications of PEO-PPO-based copolymers in the Pharmaceutical Technology field as means for attaining improved solubility, stability, release, and bioavailability of drugs.
机译:约50%的药物在生物液体中的低溶解度仍然是口服,肠胃外和经皮给药的主要限制。在克服这些缺点的现有策略中,将疏水性药物包含到聚合物胶束中是最有吸引力的替代方法之一。两亲性聚(环氧乙烷)-聚(环氧丙烷)嵌段共聚物是在水性介质中显示出独特聚集特性的热响应性材料。由于它们在水中形成稳定的胶束系统的能力,这些材料作为水溶性差的药物的增溶剂得到了广泛的研究。本综述简要介绍了基于PEO-PPO的共聚物在制药技术领域中的最重要应用,作为获得改善的药物溶解度,稳定性,释放性和生物利用度的手段。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号